The Japan regenerative medicine and cell & gene therapy cold chain logistics market, valued at USD 60.07 million in 2024, is poised for a significant surge, projected to reach USD 209.84 million by ...
The stock's rise snapped a four-day losing streak.
Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...
The Discovery Center has partnered with Thermo Fisher Scientific to launch a new exhibit called “The Lab” which teaches ...
The Discovery Center and Thermo Fisher Scientific collaborate to open a new exhibit on the 75th year the Rockford site is in ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8479 ...
Collegium Pharmaceutical is executing on commercializing its drugs and growing sales. Click here to find out why COLL stock ...
Thermo Fisher Scientific Inc has acquired Patheon NV, the Netherlands-based global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, for ...
The microbial fermentation technology market is experiencing significant growth, fueled by the increasing incidence of chronic diseases like cancer a ...
Well, welcome to the 45th Annual TD Cowen Healthcare Conference. I'm Dan Brennan, follow Tools and Diagnostics. Really pleased to be joined on stage here with Marc Casper, Chairman and President of ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry.
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results